AGP Executive Report
Last update: 11 minutes agoFDA Decision on Rare-Disease Therapy: An FDA advisory panel voted 9-3 against Capricor’s Duchenne cell therapy deramiocel, saying it didn’t show “substantial evidence” of benefit; a final FDA ruling is expected by Aug. 22. Public Health Alert (Illinois in the mix): The CDC reports suspected cyclosporiasis has surged to more than 18,000 cases across 45 states, with Illinois among states seeing rising counts tied to contaminated produce. School Mental Health Funding: Illinois AG Kwame Raoul won a temporary restraining order blocking the U.S. Department of Education from ending school-based mental health grants that serve tens of thousands of students in Illinois. Local Health & Safety: A city audit says Chicago’s rat program leans too heavily on reactive poisoning instead of proactive prevention, making long-term control unlikely. Healthcare Access Paperwork: HCSC is requiring live phone calls for ABA prior authorizations, and providers say it’s slowing approvals and creating bottlenecks. Policy & Rights: Illinois election officials told DOJ they’re complying with federal voter-roll rules, pushing back on threats tied to noncitizen voting claims.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
